Literature DB >> 24841686

Posthepatectomy liver failure after simultaneous versus staged resection of colorectal cancer and synchronous hepatic metastases.

D Patrono, G Paraluppi, M Perino, M Palisi, G Migliaretti, P Berchialla, R Romagnoli, M Salizzoni.   

Abstract

BACKGROUND: Posthepatectomy liver failure (PHLF) is the third most frequent complication and the major cause of postoperative mortality after resection of colorectal cancer liver metastases (CRLM). In case of synchronous resectable CRLM, it is still unclear if surgical strategy (simultaneous versus staged resection of colorectal cancer and hepatic metastases) influences the incidence and severity of PHLF. The aim of this study was to evaluate the impact of surgical strategy on PHLF and on the early and long-term outcome. PATIENTS AND METHODS: Retrospective study on 106 consecutive patients undergoing hepatectomy for synchronous CRLM between 1997 and 2012.
RESULTS: Of 106 patients, 46 underwent simultaneous resection and 60 had staged hepatectomy. The rate of PHLF was similar between groups (16.7% vs 15.2%; p=1) and subgroup analysis restricted to patients undergoing major hepatectomy confirmed this observation (31.8% vs 23.8%; p=0.56). Propensity-score analysis showed that preoperative total bilirubin level and the amount of intra-operative blood transfusion were independently associated with an increased risk of PHLF. Nevertheless, the risk of severe PHLF (grade B - C) was increased in patients who underwent simultaneous resection and major hepatectomy (OR: 4.82; p=0.035). No significant differences were observed in severe (Dindo - Clavien 3 - 4) postoperative morbidity (23.9% vs 20.0%; p=0.64) and survival (3 and 5-year survival: 55% and 34% vs 56% and 33%; p=0.83).
CONCLUSIONS: The risk of PHLF is not associated with surgical strategy in the treatment of synchronous CRLM. Nevertheless, the risk of severe PHLF is increased in patients undergoing simultaneous resection and major hepatectomy.

Entities:  

Mesh:

Year:  2014        PMID: 24841686      PMCID: PMC4321594     

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  40 in total

1.  Simultaneous colorectal and liver resections for synchronous colorectal metastases.

Authors:  H Sasanuma; Y Yasuda; F V Mortensen; K Yamashita; Y Nihei; N Houjou; H Chiba; A Shimizu; M Okada; H Nagai
Journal:  Scand J Surg       Date:  2006       Impact factor: 2.360

2.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

3.  Inhibition of hepatic regeneration after 70% partial hepatectomy by simultaneous resection of the bowel in rats.

Authors:  M Miyazaki; S Kohda; H Itoh; T Kaiho; F Kimura; S Ambiru; S Hayashi; E Gohchi; K Takanishi; M Nagai
Journal:  Eur Surg Res       Date:  1995       Impact factor: 1.745

4.  Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.

Authors:  Andreas A Schnitzbauer; Sven A Lang; Holger Goessmann; Silvio Nadalin; Janine Baumgart; Stefan A Farkas; Stefan Fichtner-Feigl; Thomas Lorf; Armin Goralcyk; Rüdiger Hörbelt; Alexander Kroemer; Martin Loss; Petra Rümmele; Marcus N Scherer; Winfried Padberg; Alfred Königsrainer; Hauke Lang; Aiman Obed; Hans J Schlitt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

5.  Combined colon and hepatic resection for synchronous colorectal liver metastases.

Authors:  S Lyass; G Zamir; I Matot; D Goitein; A Eid; O Jurim
Journal:  J Surg Oncol       Date:  2001-09       Impact factor: 3.454

Review 6.  Multi-modality treatment of colorectal liver metastases.

Authors:  Guo-Xiang Cai; San-Jun Cai
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

7.  Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis.

Authors:  Jinggui Chen; Qingguo Li; Changjian Wang; Huiyan Zhu; Yingqiang Shi; Guangfa Zhao
Journal:  Int J Colorectal Dis       Date:  2010-07-29       Impact factor: 2.571

8.  A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study.

Authors:  Axel Andres; Christian Toso; Rene Adam; Eduardo Barroso; Catherine Hubert; Lorenzo Capussotti; Eric Gerstel; Arnaud Roth; Pietro E Majno; Gilles Mentha
Journal:  Ann Surg       Date:  2012-11       Impact factor: 12.969

9.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

Authors:  Robert Martin; Philip Paty; Yuman Fong; Andrew Grace; Alfred Cohen; Ronald DeMatteo; William Jarnagin; Leslie Blumgart
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

10.  Surgical options for initially unresectable colorectal liver metastases.

Authors:  Irinel Popescu; Sorin Tiberiu Alexandrescu
Journal:  HPB Surg       Date:  2012-10-03
View more
  2 in total

1.  Simultaneous, Delayed and Liver-First Hepatic Resections for Synchronous Colorectal Liver Metastases: A Systematic Review and Network Meta-Analysis.

Authors:  Paschalis Gavriilidis; Konstantinos Katsanos; Robert P Sutcliffe; Constantinos Simopoulos; Daniel Azoulay; Keith J Roberts
Journal:  J Clin Med Res       Date:  2019-07-27

2.  Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis.

Authors:  Jianwei Liu; Yong Xia; Xiaorong Pan; Zhenlin Yan; Lei Zhang; Zhao Yang; Yeye Wu; Hui Xue; Shilei Bai; Feng Shen; Kui Wang
Journal:  Cancer Rep (Hoboken)       Date:  2022-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.